335 related articles for article (PubMed ID: 15676293)
1. Coping with rejection: immunosuppressants and organ transplantation.
Woodcock J
Drug Discov Today; 2005 Jan; 10(1):11-3. PubMed ID: 15676293
[No Abstract] [Full Text] [Related]
2. Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
Cowan PA; Heizer KE
Nephrol Nurs J; 2000 Dec; 27(6):623-5. PubMed ID: 16649344
[TBL] [Abstract][Full Text] [Related]
3. [Immunosuppression with sirolimus so donor kidneys survive longer].
MMW Fortschr Med; 2004 Aug; 146(31-32):46-7. PubMed ID: 15529711
[No Abstract] [Full Text] [Related]
4. [Everolimus: immunosuppression with antilymphoproliferative therapy].
Pascual J
Nefrologia; 2004; 24(2):112-23. PubMed ID: 15219086
[No Abstract] [Full Text] [Related]
5. Sirolimus for solid organ transplantation in children.
Gupta P; Kaufman S; Fishbein TM
Pediatr Transplant; 2005 Jun; 9(3):269-76. PubMed ID: 15910380
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus in pediatric patients: results in the first 6 months post-renal transplant.
Hymes LC; Warshaw BL
Pediatr Transplant; 2005 Aug; 9(4):520-2. PubMed ID: 16048606
[TBL] [Abstract][Full Text] [Related]
8. Everolimus in cardiac-transplant recipients.
Banas B; Böger C; Krämer B
N Engl J Med; 2003 Dec; 349(23):2271-2; author reply 2271-2. PubMed ID: 14657441
[No Abstract] [Full Text] [Related]
9. The ups and downs of sirolimus in kidney transplantation, and the importance of reporting negative findings.
van Gelder T
Neth J Med; 2007 Jan; 65(1):3-4. PubMed ID: 17293633
[No Abstract] [Full Text] [Related]
10. Can Rapamune replace cyclosporine? No significant difference in rejection rate after six months; long-term studies needed.
Nephrol News Issues; 2000 Aug; 14(9):S9-10. PubMed ID: 11933435
[No Abstract] [Full Text] [Related]
11. Sirolimus (Rapamune) for transplant rejection.
Med Lett Drugs Ther; 2000 Feb; 42(1071):13-4. PubMed ID: 10725969
[No Abstract] [Full Text] [Related]
12. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
Schweiger M; Wasler A; Prenner G; Stiegler P; Stadlbauer V; Schwarz M; Tscheliessnigg K
Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176
[TBL] [Abstract][Full Text] [Related]
13. [To further improve transplantation results].
Chirurg; 2002 Dec; 73(12):2 p following M392. PubMed ID: 12599314
[No Abstract] [Full Text] [Related]
14. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
15. Considerations in sirolimus use in the early and late post-transplant periods.
Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
[TBL] [Abstract][Full Text] [Related]
16. [Transplantation. Immunosuppression].
Häyry P; Gannedahl G
Nord Med; 1994; 109(6-7):191-3. PubMed ID: 8015914
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive agents in kidney transplantation].
Nishi S
Nihon Jinzo Gakkai Shi; 2011; 53(1):1-5. PubMed ID: 21370569
[No Abstract] [Full Text] [Related]
18. New paradigms in immunosuppression.
Huizinga R; Voyer T
CANNT J; 2003; 13(3):66-8. PubMed ID: 14596200
[TBL] [Abstract][Full Text] [Related]
19. [Immunosuppressive treatment: surveillance, toxicity, prospects].
Giral M; Dantal J; Soulillou JP
Rev Prat; 1994 Feb; 44(4):442-8. PubMed ID: 8184259
[TBL] [Abstract][Full Text] [Related]
20. Steroid immunosuppression in kidney transplantation: a passing era.
Schulak JA
J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
